Mauro, F.R., Molica, S., Soddu, S., Ilariucci, F., Coscia, M., Zaja, F., et al. (2020). High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). HAEMATOLOGICA, 105(11), 2671-2674 [10.3324/HAEMATOL.2019.235705].

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

Gozzetti A.;
2020-01-01

2020
Mauro, F.R., Molica, S., Soddu, S., Ilariucci, F., Coscia, M., Zaja, F., et al. (2020). High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). HAEMATOLOGICA, 105(11), 2671-2674 [10.3324/HAEMATOL.2019.235705].
File in questo prodotto:
File Dimensione Formato  
haematol 2020.pdf

accesso aperto

Tipologia: Post-print
Licenza: Creative commons
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF Visualizza/Apri
High rate of MRD-responses-Mauro-2020.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 316.77 kB
Formato Adobe PDF
316.77 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1116183